The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (Q46704299)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2011

edit

Language	Label	Description	Also known as
English	The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis	scientific article published in January 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

title

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

main subject

multiple sclerosis

0 references

patient

0 references

author

Cristina Ramo-Tello

object named as

C Ramo-Tello

series ordinal

4

0 references

author name string

V Devonshire

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

Y Lapierre

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

R Macdonell

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

F Patti

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

P Fontoura

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

L Suchet

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

R Hyde

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

I Balla

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

E M Frohman

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

B C Kieseier

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

GAP Study Group

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

publication date

1 January 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

published in

European Journal of Neurology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

volume

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

page(s)

69-77

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

cites work

Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Long-term interferon-beta treatment for multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Predicting treatment discontinuation among patients with multiple sclerosis: application of the transtheoretical model of change

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Factors leading patients to discontinue multiple sclerosis therapies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Tolerability, adverse events and compliance to glatiramer acetate in 28 patients with multiple sclerosis using the drug continuously for at least six months

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Factors that influence adherence with disease-modifying therapy in MS.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Memory impairment in multiple sclerosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Depression and multiple sclerosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.03110.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1468-1331.2010.03110.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

PubMed publication ID

20561039

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20561039

retrieved

24 December 2017

reference URL

http://europepmc.org/abstract/MED/20561039

ResearchGate publication ID

44685683

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46704299&oldid=2127612886"